Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model

Citations

WEB OF SCIENCE

37
Citations

SCOPUS

42

초록

Although immune checkpoint inhibitors have significantly improved clinical outcomes in various malignant cancers, only a small proportion of patients reap benefits, likely due to the low number of T cells and high number of immunosuppressive cells in the tumor microenvironment (TME) of patients with advanced disease. We developed a cancer vaccine adjuvanted with nanoemulsion (NE) loaded with TLR7/8 agonist (R848) and analyzed its therapeutic effect alone or in combination with immune checkpoint inhibitors, on antitumor immune responses and the reprogramming of suppressive immune cells in the TME. NE (R848) demonstrated robust local and systemic antitumor immune responses in both subcutaneous and orthotopic mouse lung cancer models, inducing tumor-specific T cell activation and mitigating T cell exhaustion. Combination with anti-PD-1 antibodies showed synergistic effects with respect to therapeutic efficacy and survival rate. Thus, NE (R848)-based cancer vaccines could prevent tumor recurrence and prolong survival by activating antitumor immunity and reprogramming immunosuppression. (c) 2021 Elsevier Inc. All rights reserved.

키워드

Immunotherapy; Adjuvant; Toll-like receptor agonist; Immunosuppression; Immune checkpoint inhibitorAbbreviations; APC; antigen-presenting cell; DC; dendritic cell; IFN; interferon; IL; interleukin; iNOS; inducible nitric oxide synthase; MDSC; myeloid-derived suppressor cell; NE; nanoemulsion; NE (R848); nanoemulsion loaded with a TLR7; 8 agonist (R848); NK; natural killer; PD-1; programmed death-1; PD-L1; PD-ligand 1; TAM; tumor-associated macrophage; TEM; transmission electron microscopy; TGF; transforming growth factor; TL; tumor lysate; TLR; Toll-like receptor; TME; tumor microenvironment; TNF; tumor necrosis factor; TUMOR-ASSOCIATED MACROPHAGES; SUPPRESSOR-CELLS; POLARIZATION; DOCETAXEL; CD39
제목
Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7/8 agonist in lung cancer model
저자
Koh, Jiae; Kim, Sohyun; Lee, Sang Nam; Kim, Sun-Young; Kim, Jung-Eun; Lee, Kyoung Young; Kim, Mi Soon; Heo, Jae Yeong; Park, Young Mee; Ku, Bo Mi; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Yang, Siyoung; Ha, Sang-Jun; Lim, Yong Taik; Ahn, Myung-Ju
DOI
10.1016/j.nano.2021.102415
발행일
2021-10
유형
Article
저널명
Nanomedicine: Nanotechnology, Biology, and Medicine
권
37